| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |